Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market sale Chief Financial Officer sold 3,524 shares at $72.69 ($256,160)
  5. 4 Planned sale Chief Executive Officer sold 20,000 shares at an average $72.48 ($1,449,628)
  6. 4 Open-market sale General Counsel and Secretary sold 3,947 shares at an average $77.15 ($304,515)
  7. 4 Open-market sale Chief Executive Officer sold 14,385 shares at an average $77.04 ($1,108,263)
  8. 4 Grant or award Director acquired 1,048,951 shares (grant or award)
  9. 4 Open-market sale General Counsel and Secretary sold 1,913 shares at $79.67 ($152,409)
  10. 4 Open-market sale Chief Executive Officer sold 6,370 shares at $79.67 ($507,498)
  11. 4 Planned sale Chief Executive Officer sold 20,000 shares at an average $80.36 ($1,607,177)
  12. 4 Planned sale Chief Executive Officer sold 50,000 shares at an average $60.51 ($3,025,573)
  13. 4 Planned sale Chief Executive Officer sold 20,000 shares at $62.50 ($1,250,058)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 26 · 502 filings